Bone Marrow Biopsy Not Needed to Stage New Hodgkin's Patients, Says Study

A new study has been published in the Journal of Clinical Oncology which could have major implications for newly diagnosed Hodgkin's patients.

According to the study, patients who have treatment-naive Hodgkin's lymphoma and who have been staged using PET/CT imaging get no benefit from a bone marrow biopsy.

Currently, the National Comprehensive Cancer Network's oncology guidelines for Hodgkin's include a bone marrow biopsy as an essential aspect of a new patient's work-up if imaging shows them to have stage IB, IIB, III or IV disease.

Tarec Chistoffer El-Galaly, M.D., of Aarhus University Hospital in Denmark, and colleagues carried out a retrospective study involving 454 patients with newly diagnosed Hodgkin's to determine whether a bone marrow biopsy added anything of use to PET/CT staging or added anything of any therapeutic value to the patient.

What they found was that among patients initially diagnosed with stage I or II disease, none of these patients had bone marrow biopsies positive for disease. Just five of the patients who had been stage III according to PET/CT were upstaged following their bone marrow biopsy, but the upstaging didn't change their treatment plan.

"To the best of our knowledge, this is the largest study to date examining the value of BMB in patients with HL who are undergoing PET/CT staging. The added diagnostic value from routine BMB was minimal, and positive BMB findings implied upstaging in only five patients from stage III to stage IV disease of a total of 454 included patients."

Source: Doctor's Lounge

More Articles

More Articles

Mantle cell lymphoma (MCL) is a rare type of B-Cell lymphoma. It presents itself in the mantle zone of lymph nodes...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

Indolent Lymphoma, or Indolent Non-Hodgkin’s Lymphomas (NHLs), are slow growing, low-grade cancers (as opposed to ...

A lymphoma prognosis varies greatly depending on the type of lymphoma. There are more than 35 types of lymphoma, including 5 types of...

Lymphomas are classified based on the type of cells involved. Non-Hodgkin’s lymphomas are marked by mutations of...

Hodgkin's Lymphoma (Disease) has a colorful history: It was not the first cancer discovered but it was one of the first in which treatments were...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

Cancer bracelets are undeniably popular, and if purchased through reliable sources such as major charities, they help contribute to the fight...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Lymphoma is a cancer of the b- and t-cell lymphocytes, part of the immune system. They account for the most frequent head and neck malignancies....

Lymphoma is a cancer of the lymphatic system, causing B-cell or...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...

As a kind of cancer, lymphoma attacks the lymphocytes and lymph nodes that are part of the immune system. Head and neck lymphoma results when...

Some cancers have clear environmental causes. Oral cancer is strongly tied to the use of chewing tobacco, and lung cancer is well-known to be much...

The Follicular Lymphoma International Prognostic Index, or FLIPI, is a standardized guide to help oncological diagnosticians accurately calculate...